DEF: Silvaco Group Sets 2026 Annual Meeting, Board Nominees

Sentiment:

Proxy Statement


Silvaco Group, Inc. announces its 2026 Annual Meeting of Stockholders to elect directors and provides updates on corporate governance, executive compensation, and related party transactions.

Delay expectedA Form 4 was filed late for Anthony Ngai on September 15, 2026, with respect to five open market purchases of Common Stock.A Form 3 and Form 4 were filed late for Christopher Zegarelli on October 8, 2025, to report his initial holdings, one open market purchase of Common Stock on September 15, 2025, and an award of RSUs on October 1, 2025, due to administrative delays in connection with a government shutdown.A Form 4 for Candace Jackson was filed late on October 6, 2025, to report the withholding of shares of Common Stock to satisfy certain tax withholding obligations associated with the settlement of vested RSUs on October 1, 2025, due to an administrative error.
Worse than expectedThe company did not achieve its Annual Performance Goals for fiscal 2025, leading to no annual performance-based bonus for current executive officers Christopher Zegarelli and Candace Jackson.Several Section 16(a) reports for executive officers and directors were filed late, indicating administrative issues in regulatory compliance.The former CEO, Dr. Babak A. Taheri, received a substantial severance package totaling over $1.7 million in cash and accelerated equity vesting, despite the company missing its performance goals for the year.

Summary

  • The Annual Meeting of Stockholders will be held virtually on Wednesday, April 22, 2026, at 9:00 a.m. local (Pacific) time.
  • Stockholders will vote to elect seven director nominees, each to serve for a one-year term expiring in 2027.
  • The record date for determining stockholders entitled to vote at the Annual Meeting is February 25, 2026.
  • Principal Stockholders, including Katherine S. Ngai-Pesic, Iliya Pesic, and Yelena Pesic, collectively own approximately 58.2% of the outstanding common stock, granting them control over director nominations.
  • The Board of Directors will be reduced from eight to seven members immediately following the Annual Meeting.
  • Baker Tilly US, LLP served as the independent auditor, with total fees of $1,190,981 in 2025 and $1,643,464 in 2024.
  • The company is classified as a 'controlled company' under Nasdaq rules, allowing exemptions from certain corporate governance requirements for its compensation and nominating/corporate governance committees.
  • Executive compensation for 2025 included Dr. Walden C. Rhines (CEO) at $231,813, Christopher Zegarelli (CFO) at $2,599,379, and Candace Jackson (SVP, General Counsel) at $541,005.
  • The company did not achieve its Annual Performance Goals for fiscal 2025, resulting in no annual performance-based bonus for current executive officers Christopher Zegarelli and Candace Jackson.
  • Former CEO Dr. Babak A. Taheri received $3,333,049 in 2025, including a $975,484 cash severance payment and $673,700 from accelerated RSU vesting upon his resignation effective August 19, 2025.
  • Related party transactions include commercial lease agreements with entities controlled by Ms. Ngai-Pesic, totaling $0.6 million in rent payments since January 1, 2025.
  • A $32.5 million settlement related to Nangate, Inc. was agreed upon in May 2025, with the company bearing 75% ($24.375 million) and Co-Defendants (Ms. Ngai-Pesic and Iliya Pesic) bearing 25% ($8.125 million); the final payment was accelerated to February 13, 2026.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing with mixed sentiment. While it highlights a commitment to corporate governance and brings in experienced directors, the missed performance goals for 2025, significant severance for the former CEO, and late regulatory filings raise concerns about operational execution and compliance. The substantial related-party transactions also warrant careful monitoring.

Positives

  • The company is committed to good corporate governance, including a Lead Independent Director, comprehensive risk oversight, regular strategic updates, and annual Board and committee self-evaluations.
  • Corporate governance highlights include majority voting for directors, no stockholder rights plan, a declassified board, an independent compensation consultant, and policies requiring pre-approval for hedging and pledging.
  • New director nominees, Dr. Cheemin Bo-Linn and Dr. Theodore L. Tewksbury III, are determined to be independent and bring extensive technology, semiconductor, financial, and public company board experience.
  • Dr. Cheemin Bo-Linn is expected to assume the role of Audit Committee Chair and be designated as an audit committee financial expert, enhancing financial oversight.
  • The Board actively seeks to improve its effectiveness, with 2025 self-evaluations revealing a desire for continued corporate governance training and direct engagement with management, which the company is addressing.

Negatives

  • The company did not achieve its Annual Performance Goals for fiscal 2025, resulting in no annual performance-based bonus for current executive officers Christopher Zegarelli and Candace Jackson.
  • Several Section 16(a) reports for executive officers and directors were filed late due to administrative delays and errors.
  • Significant related party transactions exist, including lease agreements with entities controlled by a principal stockholder (Ms. Ngai-Pesic) and a settlement agreement where principal stockholders bore only 25% of a $32.5 million payment.
  • The former CEO, Dr. Babak A. Taheri, received a substantial severance package totaling over $1.7 million in cash and accelerated equity vesting, despite the company missing its performance goals for the year.

Risks

  • The company faces general operational, economic, environmental, financial, legal, regulatory, cybersecurity, and competitive risks.
  • There is a risk of not achieving annual performance goals, which directly impacts executive compensation and could affect overall company performance and investor confidence.
  • The 'controlled company' status and significant related-party transactions present potential for conflicts of interest and may reduce independent oversight compared to non-controlled public companies.
  • Administrative issues leading to late regulatory filings could expose the company to compliance risks and potential penalties.

Future Outlook

The Board expects to appoint Mr. Ngai as Lead Independent Director following the Annual Meeting. The company intends to satisfy disclosure requirements for amendments or waivers to its Code of Ethics by posting information on its website. The company will continue to provide corporate governance training and continuing education opportunities for directors and will answer stockholder questions from the virtual annual meeting in writing on its investor relations website if time does not allow for real-time answers.

Management Comments

  • "Your vote is very important to us. Whether or not you plan to participate in the Annual Meeting, we urge you to submit your proxy or voting instructions as soon as possible to ensure your shares are represented at the Annual Meeting."
  • "The Company is committed to good corporate governance, which promotes the long-term interests of our stockholders, strengthens accountability of the Board and helps build public trust in the Company."
  • "Our Board believes that effective risk management involves our entire corporate governance framework."
  • "Silvaco's compensation program is designed to foster a pay-for-performance philosophy, aligning individual employee compensation to long-term business strategy and overall operational success."
  • "We believe that our employees are our greatest asset, and our compensation practices reflect our commitment to their contributions."

Industry Context

StockSavvy.ai notes that Silvaco operates in the critical technology computer aided design (TCAD), electronic data automation (EDA), and semiconductor intellectual property (SIP) sectors, which are foundational to the broader semiconductor industry. The company's solutions are vital for optimizing semiconductor manufacturing and accelerating time-to-market, serving industries like AI, display, power devices, automotive, memory, hyperscale computing, and IoT. The IPO in May 2024 positions Silvaco as a publicly traded entity in a highly competitive and rapidly evolving technology landscape, where strong corporate governance and strategic leadership are paramount for sustained growth and investor confidence. The appointment of experienced directors and executives with backgrounds in semiconductor and EDA industries, such as Dr. Rhines and Dr. Tewksbury, aligns with the industry's demand for deep technical and market expertise.

Comparison to Industry Standards

  • The company's 'controlled company' status, with Principal Stockholders owning 58.2% of voting power, deviates from the ideal independent board majority often seen in mature public companies like Intel (INTC) or NVIDIA (NVDA), which typically emphasize a strong independent board to mitigate potential conflicts of interest.
  • The executive compensation structure, particularly the lack of bonuses for current NEOs due to missed performance goals, reflects a pay-for-performance philosophy, which is a common industry standard. However, the significant severance package for the former CEO, Dr. Taheri, including accelerated RSU vesting and a substantial cash payment, warrants scrutiny compared to typical severance agreements in the tech sector, such as those at Broadcom (AVGO) or Qualcomm (QCOM), which are often tied more strictly to performance or specific termination clauses.
  • The disclosed related-party transactions, such as lease agreements with entities controlled by a principal stockholder, while not uncommon in private companies, are generally viewed with caution in public markets. Leading companies like Texas Instruments (TXN) or Micron Technology (MU) typically maintain stringent policies to minimize such dealings to enhance transparency and avoid perceived conflicts.
  • The late Section 16(a) filings, while attributed to administrative issues, are a governance concern. Peer companies like Applied Materials (AMAT) or KLA Corporation (KLAC) maintain robust compliance systems to ensure timely regulatory disclosures, reflecting a higher standard of operational rigor.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Executive OfficerDr. Babak A. TaheriDr. Walden C. RhinesAugust 2025Succession following previous CEO's resignation
Chief Financial OfficerNAChristopher ZegarelliSeptember 2025New appointment
SVP, General Counsel and Corporate SecretaryNACandace JacksonSeptember 2024New appointment
Chief Executive Officer and DirectorDr. Babak A. TaheriNAAugust 19, 2025Resignation
DirectorDr. Hau L. LeeNAAfter Annual Meeting 2026Not nominated for re-election
DirectorWilliam H. Molloie, Jr.NAAfter Annual Meeting 2026Not nominated for re-election
DirectorJodi L. SheltonNAAfter Annual Meeting 2026Not nominated for re-election
Board of Directors Size8 directors7 directorsImmediately following the Annual MeetingBoard recommendation to reduce size

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board CompositionThe Board size will be reduced from eight to seven directors immediately following the Annual Meeting.Immediately following the Annual MeetingPotentially streamlines decision-making and increases individual director responsibility, but reduces overall board diversity or expertise.
Board LeadershipMr. Ngai is expected to be appointed as Lead Independent Director following the Annual Meeting, succeeding Dr. Hau L. Lee.Following Annual MeetingEnsures continuity in independent oversight and leverages Mr. Ngai's financial expertise in a key leadership role.
Committee LeadershipDr. Cheemin Bo-Linn is expected to assume the role of Audit Committee Chair, bringing new financial expert leadership to this critical oversight function.Immediately following Annual MeetingStrengthens financial oversight and compliance with a new, independent financial expert chairing the Audit Committee.
Compensation PolicyQuarterly cash retainers for non-employee directors will be converted to Restricted Stock Units (RSUs) beginning with the fourth quarter of fiscal 2025.Beginning Q4 2025Further aligns director compensation with long-term shareholder value and company performance through increased equity ownership.
Regulatory Compliance/Board IndependenceThe company qualifies as a 'controlled company' under Nasdaq rules due to Principal Stockholders' ownership (58.2% voting power) and intends to avail itself of exemptions from certain independence requirements for compensation and NCG committees.OngoingAllows Principal Stockholders to maintain influence over these committees, potentially reducing independent oversight compared to non-controlled companies, which could be a governance concern for some investors.
Board EffectivenessAnnual Board evaluations in 2025 revealed directors' desire for continued corporate governance training and direct engagement with management, which the Board is addressing with twice-yearly trainings and opportunities for individual meetings.OngoingDemonstrates a proactive approach to enhancing board effectiveness, engagement, and continuous improvement in governance practices.

Legal Proceedings

  • The company, Ms. Ngai-Pesic, and Iliya Pesic agreed to a $32.5 million settlement in May 2025 in connection with a trial court judgment awarded to certain former shareholders of Nangate, Inc. The U.S. Court of Appeals for the Ninth Circuit later reversed the fraud and breach of contract verdicts, leading to an acceleration of the final settlement payment to February 13, 2026.

Related Party Transactions

  • The company has a commercial lease agreement with Kipee International, Inc., a real estate entity controlled by Ms. Ngai-Pesic (co-founder and controlling stockholder), for its corporate office in Santa Clara, California. Rent payments totaled $0.3 million since January 1, 2025. A new three-year lease was effective May 1, 2025, ending April 30, 2028.
  • The company has international office leases with New Horizons (Cambridge) LTD and New Horizons France (NHF), both real estate entities owned and controlled by Ms. Ngai-Pesic. Rent payments totaled $0.3 million since January 1, 2025. The NHC lease expires December 31, 2029; the NHF lease terminates April 30, 2026.
  • An apportionment agreement for the $32.5 million Nangate settlement stipulated that Ms. Ngai-Pesic and Iliya Pesic (Co-Defendants) would bear 25% ($8.1 million), with the company bearing the remaining 75% ($24.375 million).
  • A Consulting Advisory Agreement with Ms. Ngai-Pesic for $15,000 annually was terminated effective May 22, 2025.
  • An Amended and Restated Consulting Advisory Agreement with Mr. Iliya Pesic for $75,000 annually was terminated effective May 22, 2025.
  • A Consulting Advisory Agreement with Mr. Iliya Pesic for $40,000 annually was terminated effective May 22, 2025.

Stakeholder Impact

  • Shareholders will vote on director nominees, with Principal Stockholders maintaining significant control (58.2% voting power), which could influence governance outcomes. Missed performance goals and related-party transactions may raise questions about shareholder value protection.
  • Employees, particularly executive officers, are impacted by the company's pay-for-performance philosophy, as evidenced by the lack of annual bonuses for current NEOs due to missed 2025 performance goals.
  • Customers benefit from the company's TCAD, EDA, and SIP solutions, which are designed to optimize semiconductor manufacturing processes and accelerate product time-to-market.
  • Management has seen significant changes with new CEO, CFO, and SVP General Counsel appointments, indicating a refreshed leadership team tasked with improving performance and addressing governance issues.
  • Regulatory bodies may scrutinize the company due to late Section 16(a) filings, which indicate administrative compliance issues.

Next Steps

  • The Annual Meeting of Stockholders will be held on April 22, 2026, to elect directors.
  • The Board expects to appoint Mr. Ngai as Lead Independent Director following the Annual Meeting.
  • The Board will determine whether to accept or reject any tendered resignation from an incumbent director who does not receive a majority of votes, generally within 90 days after election results certification.
  • Public disclosure of any decision regarding tendered resignation and rationale will be made in a Current Report on Form 8-K.
  • Quarterly cash retainers for non-employee directors will be converted to RSUs, expected to be granted on the first trading day of each open trading window following the quarter earned.
  • Mr. Zegarelli is eligible to receive the second installment of his sign-on bonus upon achievement of fiscal 2026 Annual Performance Goals at or above 100% of the fiscal 2026 annual operating plan, subject to continued service through December 31, 2026.
  • The company will hold twice-yearly corporate governance trainings and provide regular updates on continuing education opportunities for directors.
  • Stockholders can submit proposals for inclusion in the 2027 annual meeting proxy statement by November 12, 2026.
  • Stockholders can submit director nominations for the 2027 annual meeting (not for proxy inclusion) between November 12, 2026, and December 12, 2026.
  • Stockholders intending to solicit proxies for director nominees under universal proxy rules must provide notice by February 21, 2027.
  • The international office lease with New Horizons France (NHF) will be terminated on April 30, 2026.

Key Dates

DateDescription
November 2012Katherine S. Ngai-Pesic joined the Board; Iliya Pesic previously served on the Board until October 2023.
October 1993Dr. Rhines served as President and CEO of Mentor Graphics Corporation until March 2017.
February 1994Jodi L. Shelton co-founded Shelton Group.
June 1994Jodi L. Shelton co-founded Global Semiconductor Alliance.
October 1997William H. Molloie, Jr. became an assurance partner at PricewaterhouseCoopers until June 2020.
November 1999Dr. Hau L. Lee co-founded DemandTec, Inc.
March 2001Katherine S. Ngai-Pesic founded Kipee International, Inc.
September 2002Dr. Hau L. Lee served as an Operations, Information and Technology Professor at Stanford University until November 2023.
June 2004Anthony K. K. Ngai served as Head of Credit Trading at J.P. Morgan Asia Pacific until September 2018.
2006Dr. Theodore L. Tewksbury III was CEO of AMI Semiconductor until 2008.
2008Dr. Theodore L. Tewksbury III served as CEO of Integrated Device Technology, Inc. until 2013.
September 2010Dr. Theodore L. Tewksbury III was a director of Entropic Communications until April 2015.
March 2011Dr. Theodore L. Tewksbury III was a board member of the Global Semiconductor Alliance (GSA) until August 2013.
February 2012Dr. Hau L. Lee served on the board of directors of TD SYNNEX Corporation until April 2025.
October 2012Katherine S. Ngai-Pesic served as president of the Marriott Business Center HOA Association.
2013Dr. Theodore L. Tewksbury III was an independent consultant to technology companies until November 2014.
2013Dr. Cheemin Bo-Linn was Chairperson and Chief Executive Officer of Peritus Partners Inc. until 2024.
April 2013Dr. Hau L. Lee served on the board of directors of Lion Rock Group Limited.
March 2014Dr. Hau L. Lee served on the board of directors of Frontier Services Group until July 2020.
June 2014Dr. Hau L. Lee served on the board of directors of Global Brands Group until September 2020.
May 2015Dr. Theodore L. Tewksbury III has been a director of MaxLinear, Inc. since this date.
June 2015Candace Jackson was a Senior Associate at the law firm of Mayer Brown LLP until March 2016.
2016Christopher Zegarelli was Chief Financial Officer of indie Semiconductor until 2019.
April 2016Candace Jackson served as Assistant General Counsel at US Foods Holding Corp. through June 2018.
February 2017Dr. Theodore L. Tewksbury III was Chairman and CEO of Energy Focus, Inc. until March 2019.
March 2017Mentor Graphics Corporation was acquired by Siemens AG.
October 2018Anthony K. K. Ngai joined the Board.
November 2018Anthony K. K. Ngai co-founded JUST FEEL.
2019Christopher Zegarelli was Chief Financial Officer of Thermal Engineering International Inc. until 2021.
August 2019Dr. Theodore L. Tewksbury III was CEO of Eta Compute until November 2021.
March 2020Dr. Walden C. Rhines served as President and Chief Executive Officer of Cornami, Inc. until June 2025.
July 2020Dr. Rhines served as a member of the board of directors of PTK Acquisition Corp. until September 2021.
July 2020Anthony K. K. Ngai served on the Board of Trustees of The Chinese University of Hong Kong, Chung Chi College.
September 2020Anthony K. K. Ngai served as a Partner of Gravity Capital Partners Co. and the Responsible Officer of Avanta Investment Management until June 2022.
March 2021William H. Molloie, Jr. became a lecturer at the University of California, San Diego Rady School of Management.
March 2021Jodi L. Shelton served on the board of directors of LF Capital Acquisition Corp.
April 2021Katherine S. Ngai-Pesic founded the Lee Ho Yee Foundation.
April 2021Baker Tilly US, LLP became the company's independent auditor.
June 2021Christopher Zegarelli was Chief Financial Officer of GaN Systems Inc. until October 2023.
July 2021Candace Jackson was Deputy General Counsel of Synaptics Incorporated from July 2021 to September 2024.
January 12, 2022Consulting Advisory Agreement with Ms. Ngai-Pesic was dated.
May 2022William H. Molloie, Jr. joined the Board and became Chair of the Audit Committee.
June 2022Anthony K. K. Ngai served as the Chief Financial Officer of Unience.io until January 2026.
September 2022Dr. Walden C. Rhines joined the Board and Audit Committee.
September 2022Jodi L. Shelton joined the Board and NCG Committee.
September 15, 2022Non-employee director compensation program was ratified.
February 2023Dr. Theodore L. Tewksbury III ceased being CEO of Velodyne Lidar.
June 2023Dr. Hau L. Lee became Lead Independent Director of Lion Rock Group Limited.
June 2023Anita Ganti served as a director of Exro Technologies until April 2024.
December 1, 2023Amended and Restated Consulting Advisory Agreement with Mr. Pesic was dated.
February 2024Executive Severance Plan was approved and became effective on February 20, 2024.
February 29, 2024Amended and Restated Employment Agreement with Dr. Taheri was entered into, effective January 1, 2024.
March 2024Anita Ganti joined the Board.
April 12, 2024Stockholders Agreement was dated.
May 8, 2024The company completed its initial public offering (IPO).
May 2024Audit Committee charter was adopted.
July 1, 2024The SMIK Trust was dissolved.
August 29, 2024Offer letter agreement with Ms. Jackson was dated.
October 1, 2024Ms. Jackson received her initial RSU Award.
December 31, 2024Fiscal year end for 2024.
January 1, 2025Vesting commencement date for 2025 RSU Awards; Dr. Taheri's 18,250 shares satisfied time-based vesting.
January 1, 2025Period for certain related party transactions began.
February 2025The Compensation Committee made RSU Awards to executives.
May 2025The company, Ms. Ngai-Pesic, and Iliya Pesic agreed to a $32.5 million settlement in connection with a trial court judgment awarded to certain former shareholders of Nangate, Inc.
May 22, 2025Consulting Advisory Agreement with Ms. Ngai-Pesic and Amended and Restated Consulting Advisory Agreement with Mr. Pesic were terminated.
May 22, 2025Non-employee directors received their 2025 annual grant of 31,250 RSUs.
August 13, 2025Offer letter agreement with Mr. Zegarelli was dated.
August 19, 2025Dr. Babak A. Taheri resigned from his roles as Chief Executive Officer and Director.
August 22, 2025The company and Dr. Taheri entered into a Separation Agreement and Release.
August 25, 2025The company and Dr. Rhines entered into an employment agreement.
September 2025Christopher Zegarelli became Chief Financial Officer.
September 2025Dr. Hau L. Lee became Lead Independent Director.
September 2024Candace Jackson became Senior Vice President, General Counsel and Corporate Secretary.
September 28, 2025Mr. Zegarelli elected to receive his sign-on bonus in ten monthly installments.
October 1, 2025Mr. Zegarelli received his initial RSU Award; Ms. Jackson's RSU vesting occurred.
October 6, 2025Candace Jackson's Form 4 was filed late.
October 8, 2025Christopher Zegarelli's Form 3 and Form 4 were filed late.
November 14, 2025Second quarterly installment payment of Nangate settlement was due.
December 1, 2025ESPP offering period began.
December 31, 2025Fiscal year end for 2025.
January 1, 2026Ms. Jackson's RSU vesting occurred.
January 2026The Board approved an amendment to the non-employee director compensation program.
February 13, 2026The final installment of the Nangate Settlement Payment was made by the company (accelerated from May 15, 2026).
February 25, 2026Record date for the Annual Meeting.
March 12, 2026Proxy materials for the Annual Meeting were first made available to stockholders.
March 12, 2026Date of the Proxy Statement.
April 21, 2026Deadline for telephone or Internet proxy voting (11:59 p.m. Eastern time).
April 22, 2026Date of the Annual Meeting.
April 30, 2026The NHF lease will be terminated.
October 1, 2026One-fourth of Mr. Zegarelli's RSUs vest.
November 12, 2026Deadline for stockholder proposals for inclusion in the 2027 proxy statement (Rule 14a-8).
December 12, 2026Latest date for stockholder proposals or director nominations not intended for proxy inclusion (advance notice requirements).
December 31, 2026Condition for Mr. Zegarelli's second sign-on bonus installment.
February 21, 2027Deadline for universal proxy rules notice for 2027 annual meeting.
March 31, 2027Term of Dr. Rhines' employment agreement ends.
2027Term for elected directors expires at the annual meeting of stockholders.
April 30, 2028New commercial lease agreement with Kipee International, Inc. expires.
October 1, 2028Ms. Jackson's initial RSU Award will be fully vested.
January 1, 2029Ms. Jackson's RSU Award of 35,224 RSUs will be fully vested.
October 1, 2029Mr. Zegarelli's initial RSU Award will be fully vested.
December 31, 2029The NHC lease expires.

Recommendation

hold

The filing presents a mixed bag of information. While Silvaco Group demonstrates a commitment to robust corporate governance practices and is bringing in highly qualified independent directors, the company's failure to meet its Annual Performance Goals for fiscal 2025 and the substantial severance package for the former CEO are concerning. The prevalence of related-party transactions and late regulatory filings also warrant caution. Given the strategic importance of the semiconductor industry and the company's foundational technology, there's long-term potential, but current operational and governance issues suggest a 'hold' stance until there's clearer evidence of consistent performance and improved compliance. Investors should monitor the new management team's ability to execute on strategic goals and address the identified governance weaknesses.

Keywords

Silvaco Group, SVCO, SEC filing, Proxy Statement, DEF 14A, Annual Meeting, Board of Directors, Corporate Governance, Executive Compensation, Semiconductor, TCAD, EDA, SIP, IPO, Nasdaq, Risk Management, Audit Committee, Compensation Committee, Nominating and Corporate Governance Committee, Related Party Transactions, Stockholders Agreement, Director Election

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.